OpenNeedle Ask your own

Question explored with the scientific record

Use of Underarm Cosmetic Products in Relation to Risk of Breast Cancer case-control study odds ratio

Oct 26, 2026 · 2 sources used · OpenNeedle synthesis
The short version: the one real case-control study here found no link between underarm products and breast cancer, and its odds ratios sit right around 1.0.

The question is about the odds ratio from a case-control study of underarm cosmetics and breast cancer. The record that matches is a population-based case-control study in Western Washington, 813 cases and 793 controls, run from late 1992 to early 1995 [2]. It looked at ever-regular antiperspirant use, exclusive antiperspirant use, deodorant use, and use within an hour of shaving [2]. The odds ratios hovered near 1.0, meaning no meaningful difference between women with and without breast cancer [2].

ExposureOdds ratioP value
Antiperspirant, ever regular use0.90.23
Deodorant, ever regular use1.20.19
Antiperspirant within 1 hour of shaving0.90.4
Deodorant within 1 hour of shaving1.20.16

An odds ratio of 0.9 means slightly fewer cases among users; 1.2 means slightly more. Neither reached statistical significance, and the confidence intervals are not in the record [2]. This is a single observational study, so it cannot prove absence of harm. It also cannot rule out a small effect in a subgroup, and it does not address long-term or cumulative exposure. The other retrieved record is about a protein in underarm sweat and has nothing to do with breast cancer, so I am not using it [1]. This retrieval is thin: one study, decades old, and no replication surfaced here.

My call: on this evidence, regular underarm cosmetic use does not show an increased breast cancer risk, but one old case-control study is weak proof of safety. Confidence: low to moderate.

Keep digging

Sources used 2

  1. Detection and quantification of apocrine secreted odor‐binding protein on intact human axillary skin International Journal of Cosmetic Science (2004) primary study Strong

    A monoclonal apo-D antibody enabled detection and quantification of ASOB2 on intact human axillary skin, revealing wide individual variation and lower ASOB2 in Chinese-descent panelists; total axillary bacterial counts did not differ between groups.

    DOI: 10.1111/j.0142-5463.2003.00203.x
  2. Antiperspirant Use and the Risk of Breast Cancer CancerSpectrum Knowledge Environment (2002) Thin

    This population-based case-control study in Western Washington found no evidence that antiperspirant or deodorant use, or use within an hour of shaving, increases breast cancer risk among women aged 20–74, regardless of shaving method.

    DOI: 10.1093/jnci/94.20.1578

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →